chr10-93594060-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006744.4(RBP4):​c.356-25G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.189 in 1,607,644 control chromosomes in the GnomAD database, including 31,431 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). There are indicators that this mutation may affect the branch point..

Frequency

Genomes: 𝑓 0.23 ( 4408 hom., cov: 32)
Exomes 𝑓: 0.18 ( 27023 hom. )

Consequence

RBP4
NM_006744.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.470

Publications

13 publications found
Variant links:
Genes affected
RBP4 (HGNC:9922): (retinol binding protein 4) This protein belongs to the lipocalin family and is the specific carrier for retinol (vitamin A alcohol) in the blood. It delivers retinol from the liver stores to the peripheral tissues. In plasma, the RBP-retinol complex interacts with transthyretin which prevents its loss by filtration through the kidney glomeruli. A deficiency of vitamin A blocks secretion of the binding protein posttranslationally and results in defective delivery and supply to the epidermal cells. [provided by RefSeq, Jul 2008]
FFAR4 (HGNC:19061): (free fatty acid receptor 4) This gene encodes a G protein-coupled receptor (GPR) which belongs to the rhodopsin family of GPRs. The encoded protein functions as a receptor for free fatty acids, including omega-3, and participates in suppressing anti-inflammatory responses and insulin sensitizing. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2012]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
This position, referring to a specific DNA site, is a probable branch point but is likely benign (scored 3 / 10, using the threshold of <=3). The score ranges from 0 to 10, with values ≤3 considered benign and >5 classified as pathogenic. Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 10-93594060-C-G is Benign according to our data. Variant chr10-93594060-C-G is described in ClinVar as [Benign]. Clinvar id is 1277035.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.337 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RBP4NM_006744.4 linkc.356-25G>C intron_variant Intron 4 of 5 ENST00000371464.8 NP_006735.2 P02753
RBP4NM_001323517.1 linkc.356-25G>C intron_variant Intron 4 of 5 NP_001310446.1 P02753
RBP4NM_001323518.2 linkc.350-25G>C intron_variant Intron 4 of 5 NP_001310447.1 P02753Q5VY30

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RBP4ENST00000371464.8 linkc.356-25G>C intron_variant Intron 4 of 5 1 NM_006744.4 ENSP00000360519.3 P02753
FFAR4ENST00000604414.1 linkc.697-10014C>G intron_variant Intron 2 of 2 3 ENSP00000474477.1 S4R3L2
RBP4ENST00000371467.5 linkc.356-25G>C intron_variant Intron 4 of 5 5 ENSP00000360522.1 P02753
RBP4ENST00000371469.2 linkc.350-25G>C intron_variant Intron 4 of 5 5 ENSP00000360524.2 Q5VY30

Frequencies

GnomAD3 genomes
AF:
0.226
AC:
34355
AN:
152000
Hom.:
4400
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.342
Gnomad AMI
AF:
0.0625
Gnomad AMR
AF:
0.193
Gnomad ASJ
AF:
0.250
Gnomad EAS
AF:
0.100
Gnomad SAS
AF:
0.342
Gnomad FIN
AF:
0.160
Gnomad MID
AF:
0.294
Gnomad NFE
AF:
0.175
Gnomad OTH
AF:
0.247
GnomAD2 exomes
AF:
0.201
AC:
48935
AN:
242910
AF XY:
0.210
show subpopulations
Gnomad AFR exome
AF:
0.345
Gnomad AMR exome
AF:
0.146
Gnomad ASJ exome
AF:
0.259
Gnomad EAS exome
AF:
0.105
Gnomad FIN exome
AF:
0.159
Gnomad NFE exome
AF:
0.179
Gnomad OTH exome
AF:
0.204
GnomAD4 exome
AF:
0.185
AC:
268929
AN:
1455526
Hom.:
27023
Cov.:
31
AF XY:
0.189
AC XY:
137226
AN XY:
724422
show subpopulations
African (AFR)
AF:
0.354
AC:
11806
AN:
33382
American (AMR)
AF:
0.150
AC:
6704
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.256
AC:
6698
AN:
26122
East Asian (EAS)
AF:
0.101
AC:
4009
AN:
39668
South Asian (SAS)
AF:
0.328
AC:
28297
AN:
86162
European-Finnish (FIN)
AF:
0.153
AC:
7809
AN:
50966
Middle Eastern (MID)
AF:
0.273
AC:
1569
AN:
5754
European-Non Finnish (NFE)
AF:
0.171
AC:
189940
AN:
1108534
Other (OTH)
AF:
0.201
AC:
12097
AN:
60226
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
10561
21121
31682
42242
52803
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6818
13636
20454
27272
34090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.226
AC:
34412
AN:
152118
Hom.:
4408
Cov.:
32
AF XY:
0.229
AC XY:
17020
AN XY:
74378
show subpopulations
African (AFR)
AF:
0.342
AC:
14170
AN:
41452
American (AMR)
AF:
0.193
AC:
2958
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.250
AC:
868
AN:
3472
East Asian (EAS)
AF:
0.101
AC:
520
AN:
5162
South Asian (SAS)
AF:
0.343
AC:
1656
AN:
4826
European-Finnish (FIN)
AF:
0.160
AC:
1697
AN:
10580
Middle Eastern (MID)
AF:
0.296
AC:
87
AN:
294
European-Non Finnish (NFE)
AF:
0.175
AC:
11880
AN:
68006
Other (OTH)
AF:
0.245
AC:
519
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1319
2638
3956
5275
6594
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
356
712
1068
1424
1780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.132
Hom.:
332
Bravo
AF:
0.232
Asia WGS
AF:
0.209
AC:
727
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
May 14, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Progressive retinal dystrophy due to retinol transport defect Benign:1
Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Microphthalmia, isolated, with coloboma 10 Benign:1
Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
4.8
DANN
Benign
0.33
PhyloP100
0.47
BranchPoint Hunter
3.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12265684; hg19: chr10-95353817; COSMIC: COSV65159758; COSMIC: COSV65159758; API